// App-Quantinova.ai

: THE RISK OF PULMONARY EMBOLISM DEVELOPMENT IN YOUNG PATIENTS WITH VENOUS THROMBOEMBOLISM COULD DEPEND ON 'GENE-GENE INTERACTION' BETWEEN PAI-1 - 675 4G/5G AND TNF-A -308 G/A POLYMORPHISMS

Researchers

Presenter

  • Sergey Kapustin

Principal Investigators

  • Anna Chechulova

  • Jane Sidorova

  • Vyacheslav Burakov

  • Vladimir Soroka

  • Vitaliy Soldatenkov

  • Lyudmila Papayan

Medical Centers

  • Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia,

  • Dzhanelidze Research Institute of Emergency Medicine, St. Petersburg, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Pulmonary embolism

Biomarkers

  • Plasminogen activator ihnibitor-1

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved